Rani Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 50
Employees
  • Latest Deal Type
  • Series E
  • Latest Deal Amount
  • $69M
Latest Deal Amount
  • Investors
  • 27

Rani Therapeutics General Information

Description

Developer of a robotic capsule designed to help people suffering from chronic diseases. The company's capsule can be applied for the treatment of diabetes, rheumatoid arthritis, psoriasis, plaque psoriasis, and ankylosing spondylitis, enabling patients to have an alternative to painful and inconvenient drug injection method.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Primary Office
  • 2051 Ringwood Avenue
  • San Jose, CA 95131
  • United States
+1 (408) 000-0000

Rani Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rani Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series E) 13-Nov-2020 $69M 00000 Completed Generating Revenue
9. Debt - General 15-Sep-2020 0000 00000 Completed Generating Revenue
8. Later Stage VC (Series D) 22-Dec-2017 000.00 00000 000 Completed Generating Revenue
7. Later Stage VC 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series C1) 08-Mar-2016 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 16-Jul-2015 000.00 000.00 Completed Startup
4. Early Stage VC (Series B) 09-Aug-2013 00.00 000.00 Completed Startup
3. Early Stage VC (Series A) 18-Jun-2012 000 00.00 Completed Startup
2. Seed Round 01-Jun-2012 $2.7M $2.7M Completed Startup
1. Spin-Off 01-Jan-2012 Completed Startup
To view Rani Therapeutics’s complete valuation and funding history, request access »

Rani Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a robotic capsule designed to help people suffering from chronic diseases. The company's capsule can be app
Drug Delivery
San Jose, CA
50 As of 2020
00000
00000000000 00000

000000 0

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
0000 00000000
New York, NY
00 As of 0000
0000
000000 - 000 0000

00000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000 00000000
Malvern, PA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rani Therapeutics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oramed Pharmaceuticals Corporation New York, NY 00 0000 000000 - 000 0000
00000000 Formerly VC-backed Malvern, PA 00 00000 00000000 00000
0000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 00000 000000&0 00000
0000000 000000000 Private Equity-Backed Boonton, NJ 00 000000000000
To view Rani Therapeutics’s complete competitors history, request access »

Rani Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
Mir Imran Founder, Chief Executive Officer & Chairman
Svai Sanford Chief Financial Officer
Mir Hashim Ph.D Chief Scientific Officer & Board Member
Rudi Ruffy Medical Director
Stephanie McGrory Vice President, Business Development
You’re viewing 5 of 10 executive team members. Get the full list »

Rani Therapeutics Board Members (7)

Name Representing Role Since
Andrew Farquharson InCube Ventures Board Member 000 0000
Blake Byers Ph.D GV Board Member 000 0000
David Pyott Self Board Member & Advisor 000 0000
Dennis Ausiello Ph.D Self Board Member 000 0000
Maulik Nanavaty Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Rani Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rani Therapeutics Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alpha Square Group Family Office Minority 000 0000 000000 0
Bossa Nova Investimentos Venture Capital Minority 000 0000 000000 0
Cathay Venture Corporate Venture Capital Minority 000 0000 000000 0
Changchun High and New Technology Industries Group Corporation Minority 000 0000 000000 0
GeneScience Pharmaceuticals Corporation Minority 000 0000 000000 0
You’re viewing 5 of 27 investors. Get the full list »